BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Choli-Papadopoulou T, Kottakis F, Papadopoulos G, Pendas S. Helicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammation. World J Gastroenterol 2011; 17(21): 2585-2591 [PMID: 21677824 DOI: 10.3748/wjg.v17.i21.2585]
URL: https://www.wjgnet.com/1007-9327/full/v17/i21/2585.htm
Number Citing Articles
1
Xing-Tang Yang, Pei-Qin Niu, Xiao-Feng Li, Ming-Ming Sun, Wei Wei, Yan-Qing Chen, Jia-Yi Zheng. Differential cytokine expression in gastric tissues highlights helicobacter pylori’s role in gastritisScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-58407-x
2
Takatsugu Goto, Yoshitoshi Ogura, Hideki Hirakawa, Junko Tomida, Yuji Morita, Takaaki Akaike, Tetsuya Hayashi, Yoshiaki Kawamura. Complete Genome Sequence of Helicobacter cinaedi Strain PAGU611, Isolated in a Case of Human BacteremiaJournal of Bacteriology 2012; 194(14): 3744 doi: 10.1128/JB.00645-12
3
Haider Rahman, Marina Kim, Galen Leung, Jesse A. Green, Seymour Katz. Drug-Herb Interactions in the Elderly Patient with IBD: a Growing ConcernCurrent Treatment Options in Gastroenterology 2017; 15(4): 618 doi: 10.1007/s11938-017-0154-y
4
Yuval Ramot, Zadik Hazan, Andre Lucassen, Konstantin Adamsky, D.P. Santhosh Kumar, S.K. Vijayasarathi, H. Krishnappa, Madhav Singh Seervi, Abraham Nyska. Toxicity and toxicokinetic study of RPh201 in Sprague-Dawley ratsFood and Chemical Toxicology 2018; 112: 168 doi: 10.1016/j.fct.2017.12.036
5
Zadik Hazan, Konstantin Adamsky, Andre Lucassen, Leonard A. Levin. A First‐in‐Human Phase 1 Randomized Single and Multiple Ascending Dose Study of RPh201 in Healthy VolunteersClinical Pharmacology in Drug Development 2020; 9(3): 366 doi: 10.1002/cpdd.720
6
Mohanraj Ramachandran, Di Yu, Alkwin Wanders, Magnus Essand, Fredrik Eriksson. An Infection-enhanced Oncolytic Adenovirus Secreting H. pylori Neutrophil-activating Protein with Therapeutic Effects on Neuroendocrine TumorsMolecular Therapy 2013; 21(11): 2008 doi: 10.1038/mt.2013.153
7
Haim Shmuely, Noam Domniz, Jacob Yahav. Non-pharmacological treatment of <i>Helicobacter pylori</i>World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(2): 171-178 doi: 10.4292/wjgpt.v7.i2.171
8
Kuo-Shun Shih, Chih-Chang Lin, Hsiao-Fang Hung, Yu-Chi Yang, Chung-An Wang, Kee-Ching Jeng, Hua-Wen Fu, William R. Abrams. One-Step Chromatographic Purification of Helicobacter pylori Neutrophil-Activating Protein Expressed in Bacillus subtilisPLoS ONE 2013; 8(4): e60786 doi: 10.1371/journal.pone.0060786
9
Jingjing Liu, Huimin Liu, Tingting Zhang, Xiyun Ren, Christina Nadolny, Xiaoqun Dong, Lina Huang, Kexin Yuan, Wenjing Tian, Yunhe Jia. Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancerScientific Reports 2014; 4(1) doi: 10.1038/srep04143
10
Keiko Morishita, Hiroaki Takeuchi, Norihito Morimoto, Tomoko Shimamura, Yoshu Kadota, Masayuki Tsuda, Taketoshi Taniguchi, Hiroyuki Ukeda, Tetsuya Yamamoto, Tetsuro Sugiura. Superoxide dismutase activity of Helicobacter pylori per se from 158 clinical isolates and the characteristicsMicrobiology and Immunology 2012; 56(4): 262 doi: 10.1111/j.1348-0421.2012.00433.x